Colgate-Palmolive (NYSE:CL) Earns Outperform Rating from Analysts at BNP Paribas

BNP Paribas started coverage on shares of Colgate-Palmolive (NYSE:CLFree Report) in a report issued on Monday morning, MarketBeat reports. The brokerage issued an outperform rating and a $109.00 target price on the stock.

A number of other equities analysts have also recently weighed in on CL. Stifel Nicolaus increased their price objective on shares of Colgate-Palmolive from $94.00 to $95.00 and gave the stock a buy rating in a research report on Monday, April 29th. Evercore ISI increased their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an outperform rating in a research report on Monday, April 8th. The Goldman Sachs Group assumed coverage on shares of Colgate-Palmolive in a research report on Friday, March 1st. They set a buy rating and a $93.00 price objective for the company. Royal Bank of Canada raised their price target on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the company a sector perform rating in a research report on Monday, April 29th. Finally, Barclays raised their price target on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the company an equal weight rating in a research report on Tuesday, April 30th. Three research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of Moderate Buy and an average price target of $93.83.

Check Out Our Latest Stock Report on CL

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $98.22 on Monday. The company has a market capitalization of $80.58 billion, a PE ratio of 31.08, a P/E/G ratio of 3.63 and a beta of 0.39. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $99.08. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.70 and a current ratio of 1.06. The company has a 50 day moving average price of $93.22 and a 200-day moving average price of $87.22.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The company had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same period in the prior year, the company earned $0.73 earnings per share. The firm’s revenue was up 6.2% on a year-over-year basis. As a group, equities analysts forecast that Colgate-Palmolive will post 3.53 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.04%. The ex-dividend date of this dividend is Friday, July 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%.

Insider Buying and Selling

In related news, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the sale, the insider now directly owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other Colgate-Palmolive news, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the transaction, the insider now directly owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Sally Massey sold 12,226 shares of Colgate-Palmolive stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the sale, the insider now owns 13,924 shares in the company, valued at $1,309,691.44. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by company insiders.

Institutional Trading of Colgate-Palmolive

A number of hedge funds and other institutional investors have recently made changes to their positions in CL. Union Savings Bank grew its stake in shares of Colgate-Palmolive by 76.6% in the 4th quarter. Union Savings Bank now owns 309 shares of the company’s stock worth $25,000 after purchasing an additional 134 shares during the last quarter. Avion Wealth increased its position in shares of Colgate-Palmolive by 78.1% in the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after acquiring an additional 175 shares in the last quarter. Atlantic Edge Private Wealth Management LLC purchased a new position in Colgate-Palmolive during the fourth quarter valued at approximately $32,000. PSI Advisors LLC lifted its stake in Colgate-Palmolive by 4,971.4% in the first quarter. PSI Advisors LLC now owns 355 shares of the company’s stock valued at $32,000 after acquiring an additional 348 shares during the last quarter. Finally, Core Wealth Advisors Inc. lifted its stake in Colgate-Palmolive by 56.6% in the fourth quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock valued at $32,000 after acquiring an additional 146 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.